Published in Lancet on March 22, 1980
Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer. Br Med J (Clin Res Ed) (1981) 0.95
Burnout and psychiatric disorder among cancer clinicians. Br J Cancer (1995) 4.47
The St Thomas' Hospital terminal care support team. A new concept of hospice care. Lancet (1981) 3.25
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol (2005) 2.65
Appropriate chemotherapy for palliating advanced cancer. BMJ (1992) 1.80
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Ann Oncol (2005) 1.66
Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy. Gut (1986) 1.59
Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol (1990) 1.48
Comparison of 5-day, 1-day, and 2-day cyclical combination chemotherapy in advanced breast cancer. Lancet (1975) 1.45
Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood (1998) 1.44
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT. Leuk Lymphoma (2000) 1.34
Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol (1998) 1.27
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer (2000) 1.16
The surgical treatment of metastatic disease of the spine. Radiother Oncol (2000) 1.14
The cyclotron saga continues. BMJ (1990) 1.07
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas. Ann Oncol (2000) 1.02
Radiotherapy in the treatment of Hodgkin's disease. Br Med J (1978) 1.01
Osteonecrosis in Hodgkin's disease. Br J Radiol (1978) 0.93
Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma. Cancer (1979) 0.92
Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med (2000) 0.89
Computer planning of stereotactic iodine-125 seed brachytherapy for recurrent malignant gliomas. Br J Radiol (1995) 0.89
The treatment of stage 3 carcinoma of the cervix by external radiotherapy and high-pressure oxygen. Br J Radiol (1969) 0.86
Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma. Radiother Oncol (1997) 0.86
XH1--a new cervical carcinoma cell line and xenograft model of tumour invasion, 'metastasis' and regression. Br J Cancer (1991) 0.85
Letter: Dangers of the clinical use of the NSD formula for small fraction numbers. Br J Radiol (1975) 0.84
Seventh interim progress report of the british institute of radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx. Br J Radiol (1982) 0.84
Localized non-Hodgkin's Lymphoma. Eur J Cancer (1980) 0.84
Breaking bad news to patients. Br J Hosp Med (1985) 0.84
A randomized, prospective, comparative, multicentre trial of a single combination versus alternating combinations of antitumour drugs in advanced breast cancer. Eur J Cancer Clin Oncol (1987) 0.83
Posttreatment laparotomy as a guide to management in patients with Hodgkin's disease. Cancer Treat Rep (1982) 0.83
Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy. Int J Radiat Oncol Biol Phys (1979) 0.82
Stress at work for the clinical oncologist. Clin Oncol (R Coll Radiol) (1996) 0.80
Malignant lymphoma in systemic rheumatic diseases. A report of five cases. Clin Exp Rheumatol (1991) 0.80
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo. Br J Cancer (1982) 0.79
Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol (1991) 0.77
Studies of the pharmacokinetic properties of nimorazole. Br J Cancer (1983) 0.77
A phase I clinical study of Nimorazole as a hypoxic radiosensitizer. Int J Radiat Oncol Biol Phys (1984) 0.76
Treatment of early carcinoma of the breast. Lancet (1979) 0.76
Recombinant human luteinizing hormone: a partial physicochemical, biological and immunological characterization. Mol Hum Reprod (1996) 0.76
The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9. Br J Obstet Gynaecol (1991) 0.76
Breakdown of small-bowel anastomoses after pelvic radiotherapy. Ann R Coll Surg Engl (1974) 0.75
Palliative care and pain management 1. Anaesthesia (2002) 0.75
The management of cervical lymph node metastases by hyperbaric oxygen and radiotherapy. Clin Radiol (1973) 0.75
Terminal pain. Nurs Mirror Midwives J (1977) 0.75
A prospective clinical trial of post-operative radiotherapy delivered in three fractions per week versus two fractions per week in breast carcinoma. Clin Radiol (1975) 0.75
Staging in Hodgkin's disease. Clin Haematol (1979) 0.75
A radiotherapists' template for use when prescribing treatment. Br J Radiol (1968) 0.75
The treatment of carcinoma of the breast. The effect of dose fractionation on survival rate. Br J Radiol (1968) 0.75
Early breast cancer. Lancet (1979) 0.75
Adjuvant chemotherapy in the treatment of breast cancer: results of a multicentre study. Eur J Surg Oncol (1986) 0.75
Comparison of 5-day and 2-day cyclical combination chemotherapy in advanced breast cancer. Clin Oncol (1979) 0.75
Osteonecrosis after intensive chemotherapy for Hodgkin's disease. Lancet (1978) 0.75
High dose-rate afterloading in the treatment of carcinoma of the cervix, 5-year results of an unusual fractionation technique. Sonderb Strahlenther Onkol (1988) 0.75
Letter: drugs for common cancers. Br Med J (1975) 0.75
Radiotherapy as salvage treatment in patients with Hodgkin's disease or non-Hodgkin's lymphoma relapsing after initial chemotherapy. Hematol Oncol (1991) 0.75
Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC). Semin Oncol (1985) 0.75
A clinician's view on palliative care, terminal care and quality of life. Eff Health Care (1985) 0.75
Treatment for lung cancer: who decides? Clin Oncol (R Coll Radiol) (1993) 0.75
Primary adenocarcinoma of the cervix: treatment and results. Br J Obstet Gynaecol (1987) 0.75
Pain and the dissatified dead. Br Med J (1978) 0.75
Treatment of Hodgkin's disease. Baillieres Clin Haematol (1987) 0.75
PET scanning in clinical oncology. Ann Oncol (1998) 0.75
The management of stage IIIA Hodgkin's disease. Int J Radiat Oncol Biol Phys (1980) 0.75
Letter: Hyperbaric oxygen combined with radiotherapy for carcinoma of the cervix. Br J Radiol (1974) 0.75
Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group. Clin Oncol (1980) 0.75
First interim progress report on the second British Institute of Radiology Fractionation Study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx. Br J Radiol (1989) 0.75
[Placing handicapped children in view of adoption]. Ugeskr Laeger (1971) 0.75